Micro Interventional Devices, Inc.™ (MID), the world leader in minimally invasive and catheter-based compliant fixation technology, received CE Mark approval for its Permaseal™ transapical access and closure device. This disruptive technology simplifies cardiovascular surgery, allowing surgeons to access and close the left-ventricle instantaneously, reliably, and without suturing the myocardium. Read more: http://prn.to/1OddZ25
Client & Alumni News
Micro Interventional Devices Receives CE Mark Approval for Permaseal™
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.